Qualcomm and IBM Expand Generative AI Collaboration

Qualcomm and IBM are teaming up to enhance generative Artificial Intelligence capabilities at the edge.

Qualcomm Technologies, Inc. and IBM have announced an expansion of their collaborative efforts to advance generative Artificial Intelligence techniques across edge devices. The focus of this partnership is to leverage IBM’s AI technologies alongside Qualcomm´s expertise in processing for edge applications. By integrating their solutions, both companies aim to offer enterprise-grade AI services that can operate efficiently on mobile and edge devices.

The collaboration is poised to benefit industries that require reliable and scalable AI processing capabilities. This includes sectors such as healthcare, automotive, and manufacturing, where real-time analysis and decision-making at the edge are crucial. The strategic alignment between Qualcomm’s hardware solutions and IBM’s AI frameworks is expected to facilitate accelerated AI deployments and enhance the overall performance of edge devices.

As data processing moves towards the periphery of networks, the innovation brought about by Qualcomm and IBM’s partnership will likely lead to improved AI-powered applications. This development reflects a growing trend where businesses adopt edge computing to minimize latency and increase the efficiency of data handling across global operations.

68

Impact Score

Crescent library brings privacy to digital identity systems

Crescent is a cryptographic library that adds unlinkability to common digital identity formats, preventing tracking across credential uses while preserving selective disclosure. It supports JSON Web Tokens and mobile driver’s licenses without requiring issuers to change their systems.

Artificial Intelligence-powered remote drug testing removes barriers to recovery

Q2i and King’s College London are collaborating to evaluate an Artificial Intelligence-powered at-home drug testing system aimed at people recovering from opioid use disorder. The solution delivers digitally observed, clinically reliable results and pairs testing with contingency management and telehealth to reduce logistical barriers to care.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.